Open Problems

Protein & Biomolecular Sequence Modeling

Quantifying and Mitigating Surrogate Oracle Exploitation in Biomolecular Sequence Optimization

Barrier to removePartly addressed
Possible candidate · 3/5 runs4 papers report this50% from 2025+

Generated automatically from the limitations stated in 4 papers (ICML, ICLR), listed under Evidence. It is not a paper, and it does not come from papers submitted to CSPaper.

The problem

Generative and reinforcement learning methods for protein design optimize against learned fitness predictors or computational proxies (such as ESMFold or AutoDock Vina) rather than ground-truth biophysical assays. As optimization progresses, generated sequences exploit the blind spots and low-label estimation errors of these surrogates, producing candidates with inflated reward scores that fail in true physical or experimental evaluations. Because contemporary literature routinely evaluates generated designs using the same surrogates that guided optimization, reported performance gains frequently reflect proxy over-optimization rather than genuine biophysical efficacy.

Why it matters

Enables trustworthy offline protein design pipelines where in silico reward gains translate to valid biophysical candidates. Establishes standard evaluation protocols that distinguish true generative capability from surrogate hacking.

Ways to approach it

Prior-work checks are free with an account. Results someone already ran are shown to everyone.

  1. 1

    Systematic over-optimization audit: Implement standard sequence optimizers (e.g., GFlowNets, RL, evolutionary search) against proxy fitness predictors across established benchmarks (e.g., ProteinGym), tracking proxy reward versus ground-truth/high-fidelity validation oracles over optimization trajectories. Measure the divergence point where proxy scores decouple from true fitness across varied training label budgets.

  2. 2

    Pessimistic and uncertainty-guided surrogate objectives: Incorporate ensemble-based epistemic uncertainty penalties (e.g., lower confidence bounds) or protein language model representation density penalties into the reward objective. Measure the retention of true oracle fitness compared to unpenalized surrogate optimization.

  3. 3

    Multi-surrogate consensus Pareto optimization: Evaluate multi-objective sequence generation across orthogonal oracle modalities (sequence-likelihood, structural prediction, and physical docking) to measure whether cross-modal consensus prevents single-predictor exploitation.

Have a different approach?

Describe how you would tackle this problem and we'll look for papers that already do it. Free; your text stays private.

Free · 3 checks per day

Why it might fail

High-fidelity validation oracles (such as extensive MD simulations or costly multiplexed wet-lab assays) may be too noisy or computationally prohibitive to establish a definitive ground-truth benchmark. Alternatively, the issue may be partially dissolved if trivial ensembling of existing foundation model embeddings already eliminates proxy exploitation across standard test sets.

Evidence

Each paper's own statement of the limitation, verbatim.

Nearest existing work

Related open problems

Protein & Biomolecular Sequence Modeling

Scope to testPartly addressed

Benchmarking the Fidelity of In Silico Protein Design Proxies Against Experimental Biophysical Assays

Generative biomolecular modeling currently assesses sequence designs almost entirely through computational surrogates—such as AlphaFold confidence (pLDDT/pTM), ESMFold self-consistency, and Rosetta energy terms—rather than physical assay measurements. Because these proxies serve as both optimization objectives and evaluation metrics, models risk overfitting to artifacts of structure-prediction heuristics rather than true biophysical viability. Without systematic evaluation against physical assays across sequence design methods, it remains unknown whether improvements on in silico leaderboards translate to viable expression, foldability, or binding in physical systems.

Possible candidate · 2/5 runs19 papers report this95% from 2025+

Protein & Biomolecular Sequence Modeling

Scope to testOpen

A Systematic Robustness Study of Genomic Foundation Models Beyond the Human Reference Genome

Current genomic sequence models are predominantly pretrained and evaluated strictly on the single human reference genome (GRCh38/hg38). Consequently, it remains unknown whether representations trained on a single reference sequence maintain their predictive capabilities across distinct chromosomes, across individual genetic variation in population-scale cohorts, or across non-human species genomes. Without cross-setting robustness benchmarks, practitioners cannot determine whether model performance transfers to non-reference genomic contexts or degrades under distribution shifts.

Possible candidate · 3/5 runs9 papers report this67% from 2025+

Protein & Biomolecular Sequence Modeling

Scope to testPartly addressed

Benchmarking Surrogate-Trained Sequence Optimization Against Empirical Fitness Landscapes

Current machine learning models for protein and biomolecular sequence design are evaluated almost exclusively against learned surrogate oracles (such as CNN fitness predictors) rather than verified experimental outcomes. Because black-box optimizers can easily exploit surrogate artifacts and out-of-distribution prediction errors, reported in-silico fitness gains often fail to reflect actual biological activity. Without systematic evaluation across empirically ground-truthed landscapes, it is unknown which sequence design methods reliably find functional sequences versus which merely overfit to computational evaluator flaws.

Strong candidate · 4/5 runs7 papers report this86% from 2025+

Protein & Biomolecular Sequence Modeling

Effect to explainPartly addressed

Benchmarking and Mitigating Model Sensitivity to Predicted Structure Quality in Protein Sequence Modeling

Current structure-conditioned protein sequence and representation models routinely filter out test proteins with predicted confidence scores below pLDDT 70 or assume near-experimental coordinate fidelity. Consequently, these models cannot reliably be applied to disordered proteins, orphan sequences, or hard-to-predict folds where high-confidence static predictions do not exist. Downstream pipelines experience unquantified error propagation when forced to consume predicted structures from AlphaFold2 or ESMFold, yet no systematic evaluation exists mapping how performance degrades across the full spectrum of structural prediction quality.

Possible candidate · 3/5 runs7 papers report this57% from 2025+
Generated automatically, not curated by hand. Automated prior-work checks catch about a third of existing work, so treat this problem as a lead to investigate.